Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

New way of data visualization in clinical trials

Munich-based software company Climedo has developed some new features for clinical trials to make it easier to visualize trial data in real time and compare patient groups across different trial centers.

How do my test subjects perform for certain laboratory parameters compared to the entire study population? What differences can be identified for certain gender or age groups or regions? Sponsors and study centers often ask themselves these and other questions. Climedo's new “Benchmarking” and “Progression” dashboard functions support sponsors and centers in visualizing and evaluating the recorded results.

Through the Benchmarkingfunction, a defined data point from a subject can be compared anonymously with the comparison value of the entire population of the study. The population can be filtered according to various information, such as gender, age group, cohort or region.

The progressionfunction makes it possible to see the development of a defined data point for a subject that was recorded over a certain period of time (e.g. over several study visits).

“With the new features, clinical studies can be carried out even more efficiently and at the same time valuable insights into the patient’s study progress can be gained,” says Veronika Schweighart, co-founder and member of the management team at Climedo. “Suppose a patient with diabetes is participating in a clinical trial for insulin. In the Climedo dashboard, the treating doctor can view his progress based on his blood sugar level or blood pressure value and see how his values compare to the entire study population and within certain weight or BMI classes. This greatly improves the transparency of the course of studies. We look forward to presenting the new features to interested parties in a personal conversation.”

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.